A growing number of lawsuits alleged that the manufacturers of certain GLP-1 drugs like Ozempic, Wegovy, and Mounjaro failed to sufficiently warn of the risks of certain severe injuries. As more ...
AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...